tebentafusp (IMCgp100)
Showing 1 - 10 of 10
Melanoma (Skin), Melanoma, Uveal Trial in Oxford (Tebentafusp)
Recruiting
- Melanoma (Skin)
- Melanoma, Uveal
-
Oxford, United KingdomChurchill Hospital, Oxford University Hospitals NHS Trust
Jul 28, 2022
Uveal Melanoma Trial in Worldwide (IMCgp100)
Active, not recruiting
- Uveal Melanoma
-
La Jolla, California
- +25 more
Mar 10, 2022
Uveal Melanoma Trial in Pittsburgh (Tebentafusp)
Not yet recruiting
- Uveal Melanoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 5, 2023
Uveal Melanoma Trial in Worldwide (IMCgp100, Dacarbazine, Ipilimumab)
Active, not recruiting
- Uveal Melanoma
- IMCgp100
- +3 more
-
Los Angeles, California
- +55 more
Mar 10, 2022
Metastatic Uveal Melanoma Trial in Paris (Pembrolizumab 25 MG/1 ML Intravenous Solution)
Recruiting
- Metastatic Uveal Melanoma
- Pembrolizumab 25 MG/1 ML Intravenous Solution
-
Paris, FranceInstitut Curie
Aug 3, 2022
Melanoma, Advanced Disease, Unresectable Trial in Philadelphia (IMCgp100 injection)
Completed
- Melanoma
- +2 more
- IMCgp100 injection
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 11, 2016